Response to “Implications of Trichomonas vaginalis Nucleic Acid Amplification Testing on Medical Training and Practice”

Similar Items

• Prevalence of Trichomonas vaginalis and Coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as Determined by the Aptima Trichomonas vaginalis Nucleic Acid Amplification Assay
  od: Ginocchio, C. C., i dr.
  Izdano: (2012)
• Implications of Trichomonas vaginalis Nucleic Acid Amplification Testing on Medical Training and Practice
  od: Smith, Lisa V., i dr.
  Izdano: (2013)
• Optimal timing for Trichomonas vaginalis test of cure using nucleic acid amplification testing
  od: Craig-Kuhn, Megan Clare, i dr.
  Izdano: (2019)
• Using multiplex nucleic acid amplification tests in the diagnosis and screening for trichomonas vaginalis and mycoplasma genitalium
  od: Woodward, James D, i dr.
  Izdano: (2021)
• A service evaluation of the Gen-Probe APTIMA nucleic acid amplification test for Trichomonas vaginalis: should it change whom we screen for infection?
  od: Hathorn, Emma, i dr.
  Izdano: (2014)